Vaccinating Italian Infants With a New Multicomponent Vaccine (Bexsero®) Against Meningococcal B Disease: A Cost-Effectiveness Analysis

Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2016.1160177